WilmerHale regularly represents clients in the life sciences industry in government investigations and litigation alleging conspiracy, fraud and abuse, including violations of the Food Drug & Cosmetic Act (FDCA), the Anti-Kickback Statute (AKS), the False Claims Act (FCA) and the Foreign Corrupt Practices Act (FCPA). Our lawyers have represented clients in criminal, civil and administrative investigations and in criminal and civil litigation brought by federal and state authorities, both at trial and on appeal. On behalf of our corporate clients, we also have conducted hundreds of internal investigations involving off-label promotion, interactions with healthcare professionals, anti-kickback issues and provided compliance advice related to other healthcare law requirements.